Delivery Order SPE2DB22D2006-SPE2DB25FW3FP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $3,093.60 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed price contract. This non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, valued at $1,180.24. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,031.20 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract, with performance completed by June 12, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $2,089.58 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,008.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 4, 2025. This is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3FPDelivery Order
The Defense Logistics Agency awarded a $1,031.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract was competitively awarded without set-aside provisions and carries an ultimate completion date of August 11, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The Dexcom G7 sensors represent a specialized medical device delivery within the company's comprehensive portfolio of pharmaceutical products and medical supplies. Through its prime IDC with DLA, the company supplies an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |